Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

10.79
Delayed Data
As of 2:09pm ET
 +0.16 / +1.51%
Today’s Change
1.46
Today|||52-Week Range
11.65
+582.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.00245.0K
 
 
Depreciation And Amortization90.0K98.0K67.0K68.0K
 
 
 
 
 
 
Operating ExpensesGross Income-90.0K-98.0K-67.0K--
 
 
 
 
General Expenses6.8M6.6M7.2M7.8M
 
 
 
 
 
Research And Development5.3M5.3M5.5M6.0M
 
 
 
 
 
Total Operating Expenses6.9M6.7M7.3M7.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.9M-6.7M-7.3M-7.7M
 
 
 
 
 
Interest Expense On Debt360.0K286.0K144.0K0.00
 
 
 
 
Other Expenses-31.0K-14.0K-3.0K-3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-7.0M-7.4M-7.7M
 
 
 
 
 
Net Income-7.3M-7.0M-7.4M-7.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.5M22.7M22.9M27.6M
 
 
 
 
 
Shares To Calculate EPS Diluted21.5M22.7M22.9M27.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.31-$0.32-$0.28
 
 
 
 
 
EPS Diluted-$0.34-$0.31-$0.32-$0.28